Mycophenolate

Mycophenolate is a medicinal product for oral use, known commercially as Cellcept.

This medicine is an immunosuppressant used to treat individuals who have undergone organ transplants.

Mycophenolate acts by preparing the body to accept the transplanted organ and inhibiting possible inflammatory reactions.

Indications for Mycophenolate

Rejection of organs in heart, kidney and liver transplants.

Side Effects of Mycophenolate

Anemia; chest pain; increased cough; difficulty breathing; blood in the urine; increased pressure; decreased white blood cells; arrhythmia; joint pain; gastrointestinal bleeding; colitis; gingivitis; muscle pain; mouth injury; problems in the pancreas; decreased platelets, tremor; abdominal pain; Headache; stomachache; nausea; vomiting; weakness; indigestion; pimples; dizziness; insomnia; skin rash.

Contraindications of Mycophenolate

Pregnancy Risk C; women in the lactation phase; hypersensitive to the product or to any of its components.

How to use Mycophenolate

Oral use

Adults

• Heart Transplant Rejection : Administer 1.5 g of Mycophenolate, 2 times daily.
• Rejection of kidney transplantation : Administer 1 g of Mycophenolate, 2 times daily.
• Rejection of liver transplantation : Administer 1.5 g of Miclofenolate 2 times daily.